0001752061-18-000001.txt : 20180906 0001752061-18-000001.hdr.sgml : 20180906 20180906133638 ACCESSION NUMBER: 0001752061-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180906 DATE AS OF CHANGE: 20180906 EFFECTIVENESS DATE: 20180906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Olaregen Therapeutix Inc. CENTRAL INDEX KEY: 0001752061 IRS NUMBER: 825352110 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-320753 FILM NUMBER: 181057243 BUSINESS ADDRESS: STREET 1: 1001 AVENUE OF THE AMERICAS STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 631-495-3467 MAIL ADDRESS: STREET 1: 1001 AVENUE OF THE AMERICAS STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 D 1 primary_doc.xml X0708 D LIVE 0001752061 Olaregen Therapeutix Inc. 1001 AVENUE OF THE AMERICAS 2ND FLOOR NEW YORK NY NEW YORK 10018 631-495-3467 DELAWARE None None Corporation true 2017 Anthony Dolisi 1001 Avenue of the Americas 2nd Floor New York NY NEW YORK 10018 Executive Officer Wesley Ramjeet 1001 Avenue of the Americas 2nd Floor New York NY NEW YORK 10018 Executive Officer Director Scott Emmens 1001 Avenue of the Americas 2nd Floor New York NY NEW YORK 10018 Executive Officer Biotechnology Decline to Disclose 06b false 2018-08-29 false true false 0 1169000 450000 719000 false 1 0 0 0 true false Olaregen Therapeutix Inc. Anthony Dolisi Anthony Dolisi CEO 2018-09-06